GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
1-Year Est. Return 70.11%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+70.11%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$287M
AUM Growth
-$23.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
78
New
Increased
Reduced
Closed

Top Buys

1
+$11.8M
2
+$8.11M
3
+$6.41M
4
KRRO icon
Korro Bio
KRRO
+$5.53M
5
SYRE icon
Spyre Therapeutics
SYRE
+$5.07M

Top Sells

1
+$8.99M
2
+$6.65M
3
+$5.92M
4
TGTX icon
TG Therapeutics
TGTX
+$5.19M
5
AXSM icon
Axsome Therapeutics
AXSM
+$4.44M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN icon
1
Biohaven
BHVN
$1.66B
$17M 5.92%
490,000
+205,000
MLTX icon
2
MoonLake Immunotherapeutics
MLTX
$1.34B
$13.2M 4.59%
300,000
SLNO
3
DELISTED
Soleno Therapeutics
SLNO
$12.2M 4.26%
300,000
+100,000
AXSM icon
4
Axsome Therapeutics
AXSM
$11.5B
$12.1M 4.2%
150,000
-60,000
ASND icon
5
Ascendis Pharma A/S
ASND
$13.6B
$11.8M 4.12%
+86,721
PCVX icon
6
Vaxcyte
PCVX
$6.96B
$11.3M 3.94%
150,000
+55,000
CRNX icon
7
Crinetics Pharmaceuticals
CRNX
$3.58B
$10.7M 3.74%
240,000
+40,000
ROIV icon
8
Roivant Sciences
ROIV
$20.6B
$10.6M 3.68%
1,000,000
-300,000
CATX icon
9
Perspective Therapeutics
CATX
$411M
$9.22M 3.21%
925,000
+325,000
TGTX icon
10
TG Therapeutics
TGTX
$5.68B
$8.89M 3.1%
500,000
-325,000
SRPT icon
11
Sarepta Therapeutics
SRPT
$1.83B
$8.69M 3.02%
55,000
-70,000
CGON icon
12
CG Oncology
CGON
$5.21B
$8.21M 2.86%
260,000
+185,000
CRBP icon
13
Corbus Pharmaceuticals
CRBP
$139M
$7.92M 2.76%
175,000
+118,059
VRDN icon
14
Viridian Therapeutics
VRDN
$1.81B
$7.65M 2.66%
587,708
-37,292
SNDX icon
15
Syndax Pharmaceuticals
SNDX
$1.65B
$7.19M 2.5%
350,000
+200,000
IMVT icon
16
Immunovant
IMVT
$6.67B
$6.86M 2.39%
260,000
+135,000
TARS icon
17
Tarsus Pharmaceuticals
TARS
$2.52B
$6.39M 2.22%
235,000
-65,000
PHAT icon
18
Phathom Pharmaceuticals
PHAT
$713M
$6.18M 2.15%
600,000
+115,000
RZLT icon
19
Rezolute
RZLT
$351M
$6.11M 2.13%
+1,421,501
OLMA icon
20
Olema Pharmaceuticals
OLMA
$1.1B
$5.95M 2.07%
550,000
+350,000
SYRE icon
21
Spyre Therapeutics
SYRE
$6B
$5.88M 2.05%
250,237
+150,237
ALNY icon
22
Alnylam Pharmaceuticals
ALNY
$38.9B
$5.47M 1.9%
22,500
-37,500
APLS
23
DELISTED
Apellis Pharmaceuticals
APLS
$5.18M 1.8%
135,000
+5,000
VKTX icon
24
Viking Therapeutics
VKTX
$3.52B
$5.04M 1.75%
95,000
+21,998
RYTM icon
25
Rhythm Pharmaceuticals
RYTM
$5.88B
$4.82M 1.68%
117,388
-7,612
1
2 3 4